Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR1405-01 Phase 2 post‑operative pain trial
CTR20221184Phase 2Completed
- Sponsor
- Nanjing Hairong Pharmaceutical Technology
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HR1405-01 in postoperative pain, pain, sponsored by Nanjing Hairong Pharmaceutical Technology. Started May 2022; status: completed.
02
Drugs
HR1405-01
03
Conditions
postoperative painpain
Beyond the preview
Go deeper on CTR20221184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221184.